Tom Meuleman is currently working as a General Manager for Amicus Therapeutics. Tom Meuleman has a wide range of experience in the pharmaceutical/biotech/diagnostics/orphan drugs and market access industry.
Metabolic, neurology, nephrology, skeletal, endocrinology, dermatology, neuro-muscular, Orphan drugs, Biopharmaceuticals.